Anti-aging effects of guanosine in glial cells

• Published in: Purinergic signalling Vol. 12; no. 4; pp. 697 - 706
• Main Authors: Souza, Débora Guerini, Bellaver, Bruna, Bobermin, Larissa Daniele, Souza, Diogo Onofre, Quincozes-Santos, André
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.12.2016; Springer Nature B.V
• Subjects: Aging; Aging - drug effects; Aging - metabolism; Animals; Astrocytes - cytology; Astrocytes - drug effects; Astrocytes - metabolism; Biomedical and Life Sciences; Biomedicine; Cancer Research; Cells, Cultured; Cerebral Cortex - cytology; Cerebral Cortex - drug effects; Cerebral Cortex - metabolism; Cytokines; Cytokines - metabolism; Glutamate-Ammonia Ligase - metabolism; Glutamic Acid - metabolism; Glutathione - metabolism; Guanosine - pharmacology; Heme Oxygenase-1 - metabolism; Human Physiology; IL-1β; Immunology; Inflammation; Male; Neurosciences; Original; Original Article; Pharmacology/Toxicology; Rats; Rats, Wistar; Aging; Adult/aged astrocytes; Heme oxygenase 1; Guanosine
• ISSN: 1573-9538; 1573-9546
• DOI: 10.1007/s11302-016-9533-4

Guanosine, a guanine-based purine, has been shown to exert beneficial roles in in vitro and in vivo injury models of neural cells. Guanosine is released from astrocytes and modulates important astroglial functions, including glutamatergic metabolism, antioxidant, and anti-inflammatory activities. Astrocytes are crucial for regulating the neurotransmitter system and synaptic information processes, ionic homeostasis, energy metabolism, antioxidant defenses, and the inflammatory response. Aging is a natural process that induces numerous changes in the astrocyte functionality. Thus, the search for molecules able to reduce the glial dysfunction associated with aging may represent an approach for avoiding the onset of age-related neurological diseases. Hence, the aim of this study was to evaluate the anti-aging effects of guanosine, using primary astrocyte cultures from newborn, adult, and aged Wistar rats. Concomitantly, we evaluated the role of heme oxygenase 1 (HO-1) in guanosine-mediated glioprotection. We observed age-dependent changes in glutamate uptake, glutamine synthetase (GS) activity, the glutathione (GSH) system, pro-inflammatory cytokine (tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β)) release, and the transcriptional activity of nuclear factor kB (NFkB), which were prevented by guanosine in an HO-1-dependent manner. Our findings suggest guanosine to be a promising therapeutic agent able to provide glioprotection during the aging process. Thus, this study contributes to the understanding of the cellular and molecular mechanisms of guanosine in the aging process.